Aegerion Pharmaceuticals Inc $28.47

down -0.24


11/7/2014 04:24 PM  |  NASDAQ : AEGR  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get AEGR Trend Analysis - it has underperformed the S&P 500 by 80%

Partner Headlines

  1. 5-Star Biotech Stock Watch: Aegerion Pharmaceuticals

    Benzinga
  2. Stocks Hitting 52-Week Lows

    Benzinga
  3. Weekly CEO Buys Highlight: GEO, TRUE, BANC, AEGR, CLMS

    GuruFocus
  4. Four CEOs Reporting Large Insider Buys

    GuruFocus
  5. Morning Market Losers

    Benzinga
  6. UPDATE: Aegerion Pharma Commences Phase 3 Clinical Trial in Japan, Will ...

    Benzinga
  7. Aegerion's JUXTAPID Capsules Approved in Mexico for Treatment of Homozygous ...

    Benzinga
  8. Leerink Swann Reiterates on Aegerion Pharmaceuticals as Weakness is Overdone

    Benzinga
  9. Canaccord Genuity Reiterates on Aegerion Pharmaceuticals as Selling is ...

    Benzinga
  10. Aegerion Pharmaceuticals Presents Data From Phase 3 Extension Study of ...

    Benzinga
  11. UPDATE: Deutsche Bank Reiterates on Aegerion Pharmaceuticals Following ...

    Benzinga
  12. Market Wrap For November 8: Markets Erase Thursday's Losses; Dow Companies ...

    Benzinga
  13. Benzinga's Top Pre-Market Gainers

    Benzinga
  14. $176,000 or $295,00 a Year: Bizarre World of Orphan Drugs

    YCharts
  15. Mid-Morning Market Update: Markets Heading Down, Dendreon Rockets Upwards

    Benzinga
  16. UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on Aegerion ...

    Benzinga
  17. Aegerion Pharmaceuticals Grants Stock Options to Purchase 55K Shares

    Benzinga
  18. My 3 Favorite Dividend Stocks at All-Time-Highs | Stock List

    GuruFocus
  19. UPDATE: Jefferies Raises PT to $29 on Aegerion Pharmaceuticals on Juxtapid ...

    Benzinga
  20. Canaccord Genuity Reiterates Buy Rating, $27 PT on Aegerion Pharmaceuticals

    Benzinga
  21. Stocks To Watch For December 26, 2012

    Benzinga
  22. Aegerion's Juxtapid OK'd

    IBD
  23. UPDATE: J.P. Morgan Reiterates Overweight Rating, Raises PT on Aegerion ...

    Benzinga
  24. FDA Approves Aegerion's' JUXTAPID Capsules for Homozygous Familial Hypercholesterolemia

    Benzinga
  25. Benzinga's M&A Chatter for Friday December 7, 2012

    Benzinga
  26. Aegerion Pharma Reserves Shares for Inducement Stock Options

    Benzinga
  27. Aegerion Pharmaceuticals Issued Patent by European Patent Office

    Benzinga
  28. BioMarin Stock Soars On Positive Drug Data

    IBD
  29. UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Aegerion ...

    Benzinga
  30. FDA EMDAC Recommends Approval of Lomitapide for Treatment of Homozygous ...

    Benzinga
  31. FDA Advisers Vote 13-2 that Aegerion Data Sufficient For Approval

    Benzinga
  32. Benzinga Mid-Afternoon Market Update

    Benzinga
  33. Benzinga Mid-Day Market Update

    Benzinga
  34. Benzinga Mid-Afternoon Market Update

    Benzinga
  35. Benzinga Mid-Morning Market Update

    Benzinga
  36. Options Alert - Aegerion Pharmaceuticals

    Benzinga
  37. UPDATE: J.P. Morgan Initiates Coverage on Aegerion Pharmaceuticals with ...

    Benzinga
  38. Aegerion Pharmaceuticals Announces Date of FDA Advisory Committee Review ...

    Benzinga
  39. Health Care Sector Wrap

    FoxBusiness
  40. Health Care Sector Wrap

    FoxBusiness
  41. Health Care Sector Wrap

    FoxBusiness
  42. Social Media Outlook for Friday June 15 (IGT, AEGR, AOL, GS)

    Benzinga
  43. Benzinga's Top Pre-Market Losers

    Benzinga
  44. Aegerion Pharmaceuticals Prices 3.4M Share Public Offering of Common Stock ...

    Benzinga
  45. Stocks To Watch For June 14

    Benzinga
  46. Aegerion Pharmaceuticals Announces Proposed Public Offering of Common Stock; ...

    Benzinga
  47. Aegerion Pharmaceuticals Comments on Standard Review Classification for ...

    Benzinga
  48. Earnings Scheduled For March 6

    Benzinga
  49. Financial Breakfast: Morning News Summary for March 5, 2012

    Benzinga
  50. Aegerion Pharmaceuticals Announces Lomitapide 78-Week Phase III Clinical ...

    Benzinga
Trading Center